Citigroup Inc Vertex Pharmaceuticals Inc Call Options Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $11.5 Million - $12.7 Million	25,100 Added 136.41%	43,500 $20.2 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $25.7 Million - $28.1 Million	-63,000 Reduced 77.4%	18,400 $7.69 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $13 Million - $15.6 Million	37,900 Added 87.13%	81,400 $33.1 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $10.7 Million - $11.4 Million	31,500 Added 262.5%	43,500 $15.1 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $3.77 Million - $4.22 Million	12,000 New	12,000 $4.22 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $7.23 Million - $8.13 Million	-25,300 Reduced 83.77%	4,900 $1.42 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $10.1 Million - $11.2 Million	-36,800 Reduced 54.93%	30,200 $8.74 Million
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $4.7 Million - $5.85 Million	20,000 Added 42.55%	67,000 $18.9 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $12.2 Million - $14.4 Million	-55,000 Reduced 53.92%	47,000 $12.3 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $5.84 Million - $7.37 Million	33,000 Added 47.83%	102,000 $22.4 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $12.5 Million - $14 Million	69,000 New	69,000 $12.5 Million

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.